Search PubMed⌕ Search

Biomedical subjects

M Lemeignan

Publications and source records attributed to M Lemeignan.

At least 37 records · Page 2Linked to original sources

Analysis of the action of 4-aminopyridine during repetitive stimulation at the neuromuscular junction.

4-Aminopyridine (4-AP) increased the quantal content (m) of end-plate potentials (e.p.p.s) evoked by continual stimulation (0.2--25 Hz) in frog end-plates depressed by Mg2+. The increase in m was due to an increase in the binomial parameter n. This was interpreted to mean that 4-AP increased the number of activated release sites. In junctions blocked by d-tubocurarine, 4-AP first increased and then decreased the amplitude of e.p.p.s. elicited during a train of stimuli of increasing frequency, indicating that 4-AP increased transmitter release more than mobilization.

Aminopyridines↗

Effects of 4-aminopyridine at the frog neuromuscular junction.

Micromolar concentrations of 4-aminopyridine (4-AP) were able to increase the amplitude of the end-plate current in frog neuromuscular junction blocked either by d-tubocurarine or by low Ca++ high Mg++ medium. The end-plate potential was also increased. These effects were reversible. The changes in the end-plate current amplitude observed after 4-AP treatment had no effect on the end-plate current time course. There was no significant difference in the resting membrane potential or mean amplitude and frequency of spontaneous miniature end-plate potentials in the presence of 4-AP. The quantal content of the end-plate potential was increased in every preparation tested and the minimal synpatic delay was lengthened in a dose-related way. 4-AP did not modify the dependence of the amplitude of the end-plate current on membrane potential. In the presence of 4-AP, the time constant of the falling phase of the end-plate current remained an exponential function of the membrane potential. The end-plate current equilibrium potential was unaffected by 4-AP. The increase in the amount of acetylcholine released by nerve impulse induced by 4-AP occurs without modification in the calcium cooperativity. The authors suggest that 4-AP, by prolonging the presynaptic action potential, could increase calcium concentration in the nerve terminal and, thus, the transmitter release.

Action Potentials↗

[Action potential changes induced by a polyflavane on normal or hypoxic guinea pig myocardial strips].

On normal isolated or stimulated Guinea-Pig myocardial strips, a polyflavane extracted from Poterium spinosum (Rosaceae) increased the duration of the action potential plateau phase. Such a modification was also elicited on hypoxic strips; in this case it did not depend on the glucose concentration in the medium; it could be related to an effect on the slow calcium-sodium channel.

Action Potentials↗

[Changes in transmitter release at frog neuromuscular junction induced by 4-aminopyridine].

4-aminopyridine (4-AP) at micromolar concentrations, increases the end-plate potential amplitude in curarized preparations and the mean quantal content in every preparation tested, but the spontaneous release is not modified by 4-AP. These results can explain the anticurare activity observed in the wole animal or in vitro. 4-AP prolongs the falling phase of the muscle action potential without change in the muscle membrane potential.

Action Potentials↗

[Electrophysiological analysis of the effects of 4-amino-pyridine in the isolated heart ventricle of the guniea pig].

The effects of 4-aminopyridine (4-AP) on guinea pig myocardial ventricular isolated strips were studied by means of intracellular microelectrodes. 4-AP increased the maximal depolarization velocity and decreased the effects of quinidine. In contrast to adrenaline, 4-AP antagonized the effects of MnCl1, but was ineffective against the alterations induced by a sodium poor solution. These findings support the suggestion that 4-AP modifies the electrophysiological membrane properties probably by increasing the Na+ inward current.

Action Potentials↗